ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Spherix Inc

Spherix Inc (SPEX)

1.63
0.00
(0.00%)
Closed January 04 4:00PM
0.00
0.00
(0.00%)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
1.63
Bid
1.56
Ask
1.58
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.63
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
5,345,000
Dividend Yield
-
PE Ratio
-0.38
Earnings Per Share (EPS)
-4.28
Revenue
2.04M
Net Profit
-22.88M

About Spherix Inc

Spherix Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Spherix Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).

Sector
Security Brokers & Dealers
Industry
Security Brokers & Dealers
Headquarters
Wilmington, Delaware, USA
Founded
-

SPEX Latest News

AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board

AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board PR Newswire NEW YORK, Feb. 3, 2021 NEW YORK, Feb. 3, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido...

Aikido Pharma Secures Early Interest in Next Generation Radiotherapy

Aikido Pharma Secures Early Interest in Next Generation Radiotherapy Currently in Human Phase 2 Trials for Treatment of Prostate Cancer PR Newswire NEW YORK, Feb. 1, 2021 NEW YORK, Feb. 1, 2021...

Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes

Company Signs Long-term Supply Agreement for Pharmaceutical D-tagatose BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Spherix Inc. (Nasdaq SPEX), an innovator in biotechnology for diabetes...

Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco

BETHESDA, Md., Jan. 11 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Announces Results of Annual Shareholders Meeting

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development

BETHESDA, Md., Sept 10 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Incorporated to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

BETHESDA, Md., Sept. 3 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services...

Spherix Announces Positive Phase 2 Study Results

Preliminary Data Demonstrates Reduction of HbA1c Levels With Doses an Order of Magnitude Lower than the Dose Used in the Current Phase 3 Trial. BETHESDA, Md., June 24 /PRNewswire-FirstCall/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

SPEX - Frequently Asked Questions (FAQ)

What is the current Spherix share price?
The current share price of Spherix is $ 1.63
How many Spherix shares are in issue?
Spherix has 5,345,000 shares in issue
What is the market cap of Spherix?
The market capitalisation of Spherix is USD 8.71M
What is the 1 year trading range for Spherix share price?
Spherix has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Spherix?
The price to earnings ratio of Spherix is -0.38
What is the cash to sales ratio of Spherix?
The cash to sales ratio of Spherix is 4.27
What is the reporting currency for Spherix?
Spherix reports financial results in USD
What is the latest annual turnover for Spherix?
The latest annual turnover of Spherix is USD 2.04M
What is the latest annual profit for Spherix?
The latest annual profit of Spherix is USD -22.88M
What is the registered address of Spherix?
The registered address for Spherix is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Spherix website address?
The website address for Spherix is www.dominariholdings.com
Which industry sector does Spherix operate in?
Spherix operates in the SECURITY BROKERS & DEALERS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
$ 144.47
(4.45%)
230.01M

Discussion

View Full Feed
Monksdream Monksdream 2 minutes ago
VIGL, under $2
https://investorshub.advfn.com/uimage/uploads/2025/1/4/yzgbzIMG_4412.gif
VIGL
jour_trader jour_trader 3 minutes ago
100% agree here. We likely aren't looking at a 3-year plan let alone 5-10. I'd prefer Elite still exist as a standalone company due the trajectory it's on, but I think we'll likely be acquired within the next couple of years. 
ELTP
georgie18 georgie18 3 minutes ago
PUMP...$9.87...🥳...Looking for Upper Channel Breakout... https://schrts.co/aPkwGxpu ...
PUMP
MartinLutherKing MartinLutherKing 3 minutes ago
https://synapse.patsnap.com/drug/ff6c315dbe7742168e9a42d545cbb7e4

https://www.bioworld.com/articles/706493-akribion-successfully-synthesizes-constructs-combining-its-g-dase-e-nuclease-with-transcodes-ttx-platform?v=preview
RNAZ
georgie18 georgie18 3 minutes ago
PUMP...$9.87...🥳...Looking for Upper Channel Breakout... https://schrts.co/aPkwGxpu ...
Konaploinks Konaploinks 4 minutes ago
Yes, U.S. Patent No. 7,716,629, issued to Vertical Computer Systems, Inc. (VCSY) on May 11, 2010, remains in force and is protected under U.S. patent law. This patent, titled “System and Method for Generating Web Sites in an Arbitrary Object Framework,” is a continuation of U.S. Patent No. 6,826,744
getmoreshares getmoreshares 5 minutes ago
Expecting updates soon-- its the NEW YEAR!
CGAC
pos_stock_hoarder pos_stock_hoarder 5 minutes ago
"Teen girls" huh? The video tells you all you need to know. You let ghetto trash get away with everything and this is what you get. Animal control is way overdue.
Konaploinks Konaploinks 5 minutes ago
Doc
It seems you’re referring to a mini kernel in the context of Vertical Computer Systems, Inc. (VCSY) and its intellectual property. If this interpretation is correct, here’s a brief explanation:

What is a Mini Kernel?

A mini kernel typically refers to a lightw
Monksdream Monksdream 5 minutes ago
SONN, under $2
https://investorshub.advfn.com/uimage/uploads/2025/1/4/fknleIMG_4411.gif
SONN
jour_trader jour_trader 5 minutes ago
Schwab has never contacted me. 
ELTP
getmoreshares getmoreshares 6 minutes ago
pulp head posting again? wonder if he got the "sign"
CGAC
jour_trader jour_trader 6 minutes ago
I completely get it and the need for redundancy. That's also why you have a maintenance crew was well to work between shifts. The old one would be most at risk.  Would love for us to be in a position to need another latest & greatest Cremer. 
ELTP
TheHound TheHound 7 minutes ago
Good try. Not enough volume. Supports at $2.40, $2.37, $2.34, $2.02, $1.89. Liquidity zone at $2.25. I suspect this will rally into the 1/15 SEC ruling and break out following if not sooner.
XRPUSD
Toronto_Trader Toronto_Trader 7 minutes ago
Who is they? New management, old company is gone. 8+ years of scam/toxic history wiped.

This a clean shell. Pretty sure Emil knows what he’s doing given he’s the only CEO on the OTC who took a ticker to Nasdaq with a subsequent massive run, called Nukkleus Inc. trading under $NUKK.
NUKK TWOH
Gmenfan Gmenfan 7 minutes ago
Megalomania without end: Now Biden is mulling a permanent ban on offshore drilling on his way out

By Monica Showalter
It's outrageous, and lawmakers had better get to work modifying that law. No sleazy bitter president, heading out of office, should have a right to determine th
Monksdream Monksdream 7 minutes ago
NRSN, under $2
https://investorshub.advfn.com/uimage/uploads/2025/1/4/yektzIMG_4410.gif
NRSN
georgie18 georgie18 7 minutes ago
NEXT...$8.23...🥳...Looking for record highs in the $25 range... Been playing this for years from $1 and up...

georgie18

Member Level
Re: georgie18 post# 102

Sunday, November 24, 2024 11:46:13 AM

Post#
143
of 1
chemist72 chemist72 7 minutes ago
Great share structure. Not like many Pink turds that have over 1 Billion OS (outstanding shares).

[pre] Outstanding Shares 368,333,637 01/03/2025
Restricted 43,588,669 01/03/2025
Unrestricted 324,744,968 01/03/2025[/pre] https://www.otcmarke
GDVM
Gmenfan Gmenfan 8 minutes ago
Megalomania without end: Now Biden is mulling a permanent ban on offshore drilling on his way out

By Monica Showalter
It's outrageous, and lawmakers had better get to work modifying that law. No sleazy bitter president, heading out of office, should have a right to determine th
georgie18 georgie18 8 minutes ago
NEXT...$8.23...🥳...Looking for record highs in the $25 range... Been playing this for years from $1 and up...

georgie18

Member Level
Re: georgie18 post# 102

Sunday, November 24, 2024 11:46:13 AM

Post#
143
of 1
boi568 boi568 8 minutes ago
Anavex certainly seems to believe the OLE results are strong, based on its release timed to the JPM conference (and a PR to that effect), as well as the April AD/PD presentation by Timo Grimmer, with its very encouraging posted abstract. Every sign is favorable.
JPM
georgie18 georgie18 8 minutes ago
NEXT...$8.23...🥳...Looking for record highs in the $25 range... Been playing this for years from $1 and up...

georgie18

Member Level
Re: georgie18 post# 102

Sunday, November 24, 2024 11:46:13 AM

Post#
143
of 1
NEXT
martyDg martyDg 8 minutes ago
And what's funny is that he gets patted on the back. He receives a lot of compliments from the cult. People are so gullible, and they really fall for the stuff he's trying to connect to NWBO. I wouldn't be surprised if next time he tries to connect Elon Musk's Starlink to NWBO. lol
NWBO
pos_stock_hoarder pos_stock_hoarder 9 minutes ago
I pledge allegiance to the mashed grapes of California!

Your Recent History

Delayed Upgrade Clock